ArticleJournal of hepatocellular carcinoma2023

Simultaneous and Sequential Use of Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Real-World Practice in China.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.